Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity-Reference-Cited by-同舟云学术

Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity

Published:2023-12-20 Issue:1 Volume:44 Page:
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

César Thibaut,Le Minh P.,Klifa Roman,Castelle Martin,Fournier Benjamin,Lévy Romain,Chbihi Marwa,Courteille Virginie,Moshous Despina,Blanche Stéphane,Alligon Mickaël,Leruez-Ville Marianne,Peytavin Gilles,Frange Pierre,Neven Bénédicte^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s10875-023-01617-1.pdf

Reference32 articles.

1. Ljungman P, et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis off Publ Infect Dis Soc Am. 2014;59(4):473–81. https://doi.org/10.1093/cid/ciu364.

2. Helou GE, Razonable RR. Letermovir for the prevention of cytomegalovirus Infection and Disease in transplant recipients: an evidence-based review. Infect Drug Resist. 2019;12:1481–91. https://doi.org/10.2147/IDR.S180908.

3. Green ML et al. ‘CMV Viral Load and Mortality after Hematopoietic Cell Transplantation: A Cohort Study in the Era of Preemptive Therapy’, Lancet Haematol. 2016;3(3):e119–e127 https://doi.org/10.1016/S2352-3026(15)00289-6.

4. Lischka P et al. ‘In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246’, Antimicrob. Agents Chemother. 2010;54(3):1290–1297. https://doi.org/10.1128/AAC.01596-09.

5. Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P. ‘The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase ▿’, J. Virol. 2011;85(20):10884–10893. https://doi.org/10.1128/JVI.05265-11.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus in haematopoietic cell transplantation - The troll is still there;Best Practice & Research Clinical Haematology;2024-09

2. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

3. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07

4. Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-05-21

5. Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice;Expert Review of Anti-infective Therapy;2024-03